BNP Paribas Financial Markets’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,125
| Closed | -$37.7K | – | 3772 |
|
|
2018
Q3 | $37.7K | Hold |
2,125
| – | – | ﹤0.01% | 2501 |
|
|
2018
Q2 | $29.3K | Buy |
+2,125
| New | +$29.3K | ﹤0.01% | 2693 |
|
|
2017
Q4 | – | Sell |
-74
| Closed | -$104 | – | 3592 |
|
|
2017
Q3 | $104 | Hold |
74
| – | – | ﹤0.01% | 3488 |
|
|
2017
Q2 | $111 | Sell |
74
-66
| -47% | -$99 | ﹤0.01% | 3525 |
|
|
2017
Q1 | $360 | Sell |
140
-1,850
| -93% | -$4.76K | ﹤0.01% | 3311 |
|
|
2016
Q4 | $5.08K | Sell |
1,990
-577
| -22% | -$1.47K | ﹤0.01% | 3113 |
|
|
2016
Q3 | $7.93K | Buy |
2,567
+1,080
| +73% | +$3.34K | ﹤0.01% | 3278 |
|
|
2016
Q2 | $4.77K | Buy |
+1,487
| New | +$4.77K | ﹤0.01% | 3290 |
|
|
2016
Q1 | – | Sell |
-7,006
| Closed | -$28.1K | – | 3353 |
|
|
2015
Q4 | $28.1K | Sell |
7,006
-754
| -10% | -$3.02K | ﹤0.01% | 3156 |
|
|
2015
Q3 | $35.5K | Buy |
7,760
+4,637
| +148% | +$21.2K | ﹤0.01% | 3085 |
|
|
2015
Q2 | $16.2K | Buy |
3,123
+2,263
| +263% | +$11.7K | ﹤0.01% | 3177 |
|
|
2015
Q1 | $5.38K | Buy |
+860
| New | +$5.38K | ﹤0.01% | 3115 |
|
|
2014
Q4 | – | Sell |
-3,040
| Closed | -$18.5K | – | 3177 |
|
|
2014
Q3 | $18.5K | Buy |
+3,040
| New | +$18.5K | ﹤0.01% | 2757 |
|
|
2014
Q1 | – | Sell |
-395
| Closed | -$4.22K | – | 3418 |
|
|
2013
Q4 | $4.22K | Buy |
+395
| New | +$4.22K | ﹤0.01% | 2716 |
|
|
2013
Q3 | – | Sell |
-10,658
| Closed | -$140K | – | 2417 |
|
|
2013
Q2 | $140K | Buy |
+10,658
| New | +$140K | ﹤0.01% | 2136 |
|